Freyr has signed a strategic artwork and labelling contract with a Switzerland based, fast growing Generic Pharmaceutical & CMO.

The upcoming project for Swiss market is scheduled for completion within a year, for which Freyr will provide end-to-end regulatory artwork and labelling services covering graphic designing, proof reading and publishing ready documents basing on regulatory requirements of the HAs.

On this new strategic artwork and labelling contract, Sudheer Goparaju, VP Global Operations for Freyr said, “As the regulatory environment continues to become increasingly stringent, Freyr is focusing to create solutions to help clients leverage a globally scalable and efficient labelling and artwork management ecosystem to effectively meet the needs of the global life sciences industry. Freyr is excited to add the leading Europe based generic pharmaceutical company to our growing list of clients.”